Skip to main content
. Author manuscript; available in PMC: 2017 Nov 8.
Published in final edited form as: Oncogene. 2017 May 8;36(25):3629–3639. doi: 10.1038/onc.2017.123

Table 4.

Clinical and Pathological characteristics of Prostate Cancer Samples

Pathological stage Number Gleason scores Recurrent *PC free* Undetermined outcome+
T2a 5 5–7 3/7 2/7    2/7
T2b 115 6–10 45/115 69/115    1/115
T2c 2 5,7 1/2 1/2    0/2
T3a 23 6–8 11/23 12/23    0/23
T3b 14 7–9 7/14 7/14    0/14
T3c 1 7 0/1 1/1    0/1
T4 3 8 0/3 3/3    0/3
*

- clinical follow-up for 5 years;

+

- No adequate clinical follow-up.